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Abstract
Translation is a regulated process and is pivotal to proper cell growth and homeostasis. All retroviruses rely on the host
translational machinery for viral protein synthesis and thus may be susceptible to its perturbation in response to stress, co-
infection, and/or cell cycle arrest. HIV-1 infection arrests the cell cycle in the G2/M phase, potentially disrupting the
regulation of host cell translation. In this study, we present evidence that HIV-1 infection downregulates translation in
lymphocytes, attributable to the cell cycle arrest induced by the HIV-1 accessory protein Vpr. The molecular basis of the
translation suppression is reduced accumulation of the active form of the translation initiation factor 4E (eIF4E). However,
synthesis of viral structural proteins is sustained despite the general suppression of protein production. HIV-1 mRNA
translation is sustained due to the distinct composition of the HIV-1 ribonucleoprotein complexes. RNA-coimmunopre-
cipitation assays determined that the HIV-1 unspliced and singly spliced transcripts are predominantly associated with
nuclear cap binding protein 80 (CBP80) in contrast to completely-spliced viral and cellular mRNAs that are associated with
eIF4E. The active translation of the nuclear cap binding complex (CBC)-bound viral mRNAs is demonstrated by ribosomal
RNA profile analyses. Thus, our findings have uncovered that the maintenance of CBC association is a novel mechanism
used by HIV-1 to bypass downregulation of eIF4E activity and sustain viral protein synthesis. We speculate that a subset of
CBP80-bound cellular mRNAs contribute to recovery from significant cellular stress, including human retrovirus infection.
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Introduction
Regulation of translation is a fundamental property of cell
physiology. In dividing cells, mRNA translation is robust in the G1
growth phase, diminishes during the S phase, and is downregu-
lated during the G2/M phase [1,2,3]. In the virus-infected cell,
pathogen-associated molecular patterns trigger signaling cascades
that downregulate mRNA translation to generate a protective,
antiviral state [4,5,6]. This involves post-translational modification
of components of the mRNA-ribonucleoprotein complexes
(mRNPs) that are necessary for translation [7,8,9]. The resump-
tion of protein synthesis involves loading of ribosomes at the 59
untranslated region (UTR) of the mRNA. Determination of the
mRNP components that modulate resumption of protein synthesis
remains an active area of study.
The mRNP is initially formed upon addition of 7-methylgua-
nosine to the 59 end of the RNA, triggering binding of the nuclear
cap binding complex (CBC, composed of CBP80 and CBP20)
[10]. The CBC remains a component of the RNP during intron
removal, deposition of the exon junction complex (EJC) and
nuclear export. In the cytoplasm, the CBC is sufficient for an
initial round of mRNA translation. If the ribosome encounters a
termination codon before an EJC, a rearrangement of the RNP is
triggered that culminates in the degradation of mRNA by
nonsense mediated decay (NMD) [11]. Alternatively, if the
ribosome encounters a termination codon after an EJC, a
rearrangement of the RNP is triggered that circumvents NMD
and the mRNA undergoes steady state translation. Part of the
RNP rearrangement involves the replacement of the CBC by the
cytoplasmic cap-binding protein, eIF4E, and the replacement of
the nuclear polyadenylate binding protein (PABP-N) at the 39 end
of the mRNA by the cytoplasmic PABP-1. eIF4E is the rate-
limiting component of the translation initiation machinery and
downregulation of eIF4E activity attenuates steady state mRNA
translation [1,3,12]. eIF4E function is regulated by posttransla-
tional modifications. Hypophosphorylation of eIF4E and/or the
eIF4E-binding proteins (4E-BPs) downregulates the activity of
eIF4E by blocking interaction with eIF4G [13,14]. In contrast,
hyperphosphorylation of the 4E-BPs increases the interaction of
eIF4E and eIF4G, facilitating translation initiation.
Downregulation of the eIF4E activity is a strategic tool for cells
to rapidly respond to stress or alterations in cell cycle progression
[1,15,16]. The modulation of the eIF4E activity has proven
beneficial for the members of the Picornaviridae (e.g. poliovirus,
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of eIF4E, these viruses inhibit the synthesis of the host proteins
while favouring synthesis of viral proteins [18]. The translation of
picornaviral mRNAs persists by use of eIF4E-independent internal
ribosome entry sites (IRES) [17]. Conceivably, the CBC-bound
mRNAs would be capable of sustaining translation during
downregulation of eIF4E-dependent translation [19].
In contrast to most host mRNAs, expression of the HIV-1
mRNA encoding the viral structural proteins is dependent upon
an alternate pathway for the export of the corresponding mRNAs.
While bulk mRNA export uses NXF1 as the export mediator,
transport of HIV-1 unspliced and singly spliced RNAs to the
cytoplasm involves use of the rRNA and tRNA export factor,
CRM1 [20,21]. At present, it is unclear whether the use of an
alternate export pathway is necessary to bypass control mecha-
nisms that block export of incompletely spliced mRNAs to the
cytoplasm, or is necessary to confer a unique pattern of
cytoplasmic regulation.
In addition to the interaction of the HIV-1 RNA with the host
gene expression machinery, the HIV-1 protein products interact
with cellular pathways to induce alterations in cell function [22]. A
case in point is HIV-1 viral protein R (Vpr) which alters cell cycle
progression by arresting cells in the G2/M phase [23]. Vpr-
induced G2/M arrest also appears to contribute to the
pathogenesis of HIV-1 based on the positive selection for Vpr in
HIV-1 infected individuals and enhancement of virion production
in cells [24,25]. In light of the known interaction between the cell
cycle and translation control, it is possible that mRNA translation
is attenuated during viral infection [1,3,26]. How viral protein
synthesis could be maintained under conditions of reduced host
translation remains an open question. In this report, we
demonstrate that the virus-induced G2/M arrest is necessary
and sufficient to downregulate host protein synthesis. Further-
more, Vpr is sufficient for the observed reduction in global
translation. The mechanism is the downregulation of eIF4E
activity. Despite the reduced level of global translation during
HIV-1 infection, synthesis of viral protein is maintained. Analysis
of the components of the viral RNP revealed that, in contrast to
the host cell mRNAs, HIV-1 incompletely spliced RNAs retain
interaction with the CBC during translation and packaging into
virions. The unique composition of the viral mRNPs may explain
the sustained translation of the unspliced viral mRNA during
downregulation of the host translation machinery.
Materials and Methods
Expression plasmids and proviruses
HIV-1
NL4-3 was obtained from AIDS Reagent Reference
Program. pHRvprIRESgfp, pHRvpr(R80A)IRESgfp, pHRvpr
(Q65R)IRESgfp, pHRvpr(R80A/Q65R)IRESgfp and pNL4-3-
VprX were obtained from Vicente Planelles (University of Utah)
[27,28]. pHRvprIRESgfp was digested with SalI-XhoI and the
backbone was religated to generate pHR-IRESgfp. pNL4-3-VprX
and pHIV-1
NL4-3DVif were digested with NheI-PflMI and
religated to generate DVifVprX. HIV-1
HXB2R-RI2 was obtained
from Eric Cohen (Universite de Montreal) [29]. The RNA probe
spanning the major splice donor of HIV-1 was constructed by PCR
on the template HxBRU with the primers gagSDF (59-CGC-
GGATCCGAAGTAGTGTGTGCCCGTCT-39) and gagSDR
(59-CCCAAGCTTCCCTGCTTGCCCATACTATA-3). All plas-
mid preparations were confirmed by DNA sequence analysis.
Cells, infections and transfections
CEMx174 lymphocytes were grown in RPMI with 10% fetal
bovine serum and 1% antibiotic/antimycotic. HEK293 cells were
grown in DMEM with 10% fetal bovine serum and 1% antibiotic/
antimycotic. HEK293 cells were transfected with the indicated
HIV-1
NL4-3 molecular clone and cell-free supernatants were
collected and used to infect CEMx174 lymphocytes. Typically
one million CEMx174 cells were incubated with 8610
6 pg of cell-
free Gag for 2 h to generate HIV-1 producer cells. Coculture
infections combined producer and naive CEMx174 cells at 1:10
ratio and intracellular Gag production was evaluated by flow
cytometry beginning at 8 h for indicated intervals. At 32 and 46 h
post-infection, the cocultures were treated with nocodazole (Noc,
0.4 mg/ml) for 16 h and cyclohexamide (CHX, 100 mg/ml) for
2 h, respectively. HEK293 cells were treated with 1 mM
nocadozole for 24 hours. HEK293 cells (2610
5) were transfected
for 48 h in 6-well plates with 1 mg of indicated plasmid, FuGene 6
(Roche) following manufacturer’s protocol.
Ribosome profile analyses
Ribosomal profiles were prepared as described previously [30].
Briefly, 1610
7 cells were treated with 200 mM cycloheximide for
15 min at 37uC, washed in cold PBS containing 200 mM
cycloheximide, collected by centrifugation at 1540 rpm for
4 min, and lysed in 450 ml gradient buffer (10 mM Hepes,
7 mM MgCl, 10 mM NaCl, 3 mM CaCl, 1 mM DTT, 0.5%
NP40, supplemented with 2 ml/mL RNAsin and 1 ml/ml
cycloheximide). For EDTA treatment, 30 mM EDTA was added
to the PBS and gradient buffer. Lysates were layered on the linear
sucrose gradients (15–47.5%) and centrifuged at 36,000 rpm for
2.25 h at 4uC in SW41 rotor (Beckman). Gradients were
fractionated and A254 absorbance was measured using an ISCO
system. Alternative fractions were collected for RNA or protein
isolation. For RNA isolation, fractions were treated with an
equivalent volume of 100% ethanol and tRNA (1 mg). For protein
isolation, fractions were equilibrated in 10% TCA. Samples were
incubated at 280uC overnight and centrifuged at 16,000 g for
20 min, and extracted with Trizol (Invitrogen) by the manufac-
turer’s protocol.
Author Summary
Retroviruses are intracellular parasites that utilize the host
translation machinery to catalyze viral protein synthesis.
The activity of the translation machinery fluctuates during
cell cycle progression and is reduced in the G2/M phase.
HIV-1 infection causes the cells to arrest in the G2/M phase,
which has the potential to alter the activity of the
translation machinery. Herein several lines of evidence
demonstrated that lymphocyte mRNA translation is
suppressed by the action of HIV-1 accessory protein Vpr.
The molecular basis of translation suppression is reduced
activity of the rate-limiting translation intitation factor,
eIF4E. However, synthesis of the viral structural proteins is
sustained and is due to the difference in composition of
the viral and cellular mRNA-ribonucleoprotein complexes.
Both cellular and completely spliced viral mRNAs are
predominantly associated with the cytoplasmic cap
binding protein, eIF4E. In contrast, unspliced HIV-1 mRNAs
are predominantly associated with the components of the
nuclear cap binding complex (CBC). The retention of CBC
on the viral mRNAs provides a mechanism to sustain viral
protein synthesis. This newly characterized interface of the
virus-host-protein synthesis machinery is likely a cellular
adaptation used to enable synthesis of proteins that
reengage the cell cycle and facilitate recovery from stress.
HIV-1 Retains Nuclear RNP to Foster Translation
PLoS Pathogens | www.plospathogens.org 2 March 2012 | Volume 8 | Issue 3 | e1002612To fractionate cytosolic RNPs and membrane-associated RNPs,
CEMx174cells(6610
7) werecollectedandresuspendedin110 mM
KOAc, 25 mM K-HEPES (pH 7.5), 2.5 mM Mg(OAc)2, 1 mM
EGTA, 1 mM DTT, 1 mM PMSF, 200 mM CHX, 50 U/mL
RNasin (Promega), 150 mg/mL digitonin (Sigma) [31], incubated
on ice for 5 min and centrifuged at 10,000 g for 10 min at 4uC. The
supernatant containing soluble cytosolic RNPs was collected. The
pellet containing membrane-associated RNPs was rinsed twice with
ice-cold cytosol buffer lacking detergent and extracted in 400 mM
KOAc, 25 mM K-HEPES (pH 7.5), 15 mM Mg(OAc)2,1m M
DTT, 1 mM PMSF, 200 mM cycloheximide, 50 U/mL RNasin
(Promega), 20 mg/mL digitonin. The suspension was incubated on
ice for 30 min, centrifuged at 10,000 g for 10 min at 4uC, and the
supernatant was collected. Aliquots of the preparations were
reserved for immunoblotting.
Flow cytometry
Intracellular staining of Gag with FITC conjugated anti-Gag
p24 antibody (KC57-FITC, Beckman Coulter) was used to
monitor the progress of viral infections. Cells were fixed and
permeabilized with Cytofix/Cytoperm kit (BD Biosciences)
according to manufacturer’s protocol. Cell cycle analyses were
performed using propidium iodide (PI) staining. Briefly, 5610
5
cells were incubated in hypotonic PI staining buffer (0.1% Sodium
Citrate, 0.3% Triton-X, 100 mg/ml PI and 20 mg/ml RNase A)
for 30 min on ice followed by flow analysis. ModFit generated the
cell cycle profiles. GFP expression was analyzed on a FACS Aria
cell sorter.
Metabolic labeling
Cell cultures were rinsed and incubated for 30 min in RPMI
supplemented with 10% dialyzed FBS that lacked methionine and
cysteine, followed by addition of [
35S]-cysteine/methionine (MP
Biomedicals) (50 mCi/ml). After incubation for 1 hour, the cells
were rinsed with PBS and lysed in 50 mM Tris pH 8.0, 0.1%
SDS, 1% Triton-X, 150 mM NaCl, 1% deoxycholic acid, 2 mM
PMSF. Cell lysates were equilibrated to 10% TCA with 50 mg
bovine serum albumin and 0.01% sodium azide and incubated on
ice for 30 min. Samples were applied to glass fiber filters, washed
twice with ice cold 10% TCA and 100% ethanol, respectively. The
[
35S]-cysteine/methionine-labeled proteins were measured by
scintillation or visualized by SDS PAGE. Gag or Actin proteins
were collected by IP using 1 ml of Gag antibody [32] or actin
antibody (Abcam ab6276) on Protein A Sepharose beads (GE
Healthcare). After SDS PAGE, [
35S]-cysteine/methionine-labeled
proteins were detected by Phosphorimager analysis as described
previously [33].
RNP immunoprecipitation and immunoblot
CEMx174 cells (1610
7) were washed twice with PBS and
harvested on ice in lysis buffer supplemented with 100 U of
RNaseOUT (Invitrogen) as described previously [34]. IP were
performed on Protein A Sepharose beads that had been
conjugated to CBP80 (Bethyl A 301–794A, 5 mg) or eIF4E (Santa
Cruz sc-9976, 5 mg) antiserum prior to incubation with cytoplas-
mic extract (250 mg). After overnight incubation at 4uC, complexes
were washed twice with low salt RIPA buffer (50 mM Tris pH 8.0,
0.1% SDS, 1% Triton-X, 150 mM NaCl, 1% deoxycholic acid)
plus 2 mM PMSF and 2 ml/ml RNaseOUT (Invitrogen); followed
by one wash with high salt RIPA buffer (50 mM Tris pH 8.0,
0.1% SDS, 1% Triton-X, 1 M NaCl, 1% deoxycholic acid) plus
2 mM PMSF and 2 ml/ml RNaseOUT. IP efficiency was assessed
by immunoblotting of equivalent aliquots of input lysate and
washed bead slurry (15 ml). RNA was extracted from the
immunoprecipitates using Trizol (Invitrogen) following manufac-
turer’s protocol.
The antibodies used for immunoblotting were: CBP80 (Bethyl
A301–793A), eIF4E (Cell Signaling 9742), GRP78 (Abcam
ab21685), a-tubulin (Santa Cruz sc-23948), HA.11 (Covance
MMS-101R), HIV-1 Vif (6459, NIH AIDS reagent program),
PARP (Cell Signaling 9542), b-Actin (Abcam ab6276), phospho-
eIF2a Ser51 (Cell Signaling 3597), total eIF2a (Cell Signaling
9722), phospho-eIF4E Ser209 (Cell Signaling 9741), total eIF4E
(Cell Signaling 9742), phospho-4E-BP1 Ser65 (Cell Signaling
9451), total 4E-BP1 (Cell Signaling 9452), phospho-Mnk1
Thr197/202 (Cell Signaling 2111), total Mnk1 (Cell Signaling
2195), Caspase-3 (Cell Signaling 9662) and CBP80 (Bethyl A301–
793A).
RNA analyses
The reverse transcription (RT) reactions were carried out using
the Omniscript reverse transcriptase (Qiagen), random hexamers
and 100 ng of cellular RNA or equivalent volumes of RNA eluant
from the RNA-IP samples. Ten-percent of the RT reaction was
subjected to real-time PCR quantification on Lightcycler (Roche)
or standard PCR amplification followed by electrophoresis on
1.5% agarose and detection by ethidium bromide. Thirty cycles of
PCR were performed using the following primers and annealing
temperatures: HIV-1 gag forward KB1614 59-GTAAGAA-
AAAGGCACAGCAAGCAGC and HIV-1 gag reverse, KB1615
59-CATTTGCCCCTGGAGGTTCTG; 57uC. nef forward
KB1330 59-CGGCGACTGGAAGAAGCG and nef reverse
KB1331 59-CTCGGGATTGGGAGGTGGGTC; 58uC. gapdh
forward KB1371 59-CATCAATGACCCCTTCATTGAC and
gapdh reverse KB1372 59-CGCCCCACTTGATTTTGGA;
52uC. The RNase protection assay (RPA) was performed as
described previously [35,36].
Statistical analyses
Sample size of three observations per treatment provided more
than 95% power to detect differences in the experiments
performed in this study. Treatment groups consisted of three or
more independent biological replicate samples. As previously
established [34], significant differences among groups or treat-
ments were measured by one-way ANOVA models; multiple
comparisons of the treatments to the mock control used Dunnett
simultaneous tests; pairwise comparisons employed Tukey’s
method. Log transformation was performed on the outcome
variable and two-sided tests were used to calculate probability (p-
value).
Results
Suppression of cellular translation is attributable to HIV-
1-induced cell cycle arrest
To examine the impact of HIV-1 infection on the translational
activity of lymphocytes, a series of complementary experiments
were performed. Previously, ribosomal RNA profile analysis
revealed a subtle change in the polyribosome profile of HIV-
infected lymphocytes, suggesting a reduction in cellular translation
[37]. To revisit this observation, sucrose gradient were performed
and ribosomal RNA profiles were generated on soluble ribosomes
and membrane-associated ribosomes. In comparison to uninfected
CEMx174 cells, HIV-1 infected cells displayed a subtle reduction
in the amplitude of polyribosome peaks (Figure 1A, Cytosol,
compare area under the dotted line), recapitulating the published
results [37]. Furthermore, the difference was observed in both the
soluble- and membrane-associated ribosomal RNA profiles
HIV-1 Retains Nuclear RNP to Foster Translation
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with Tubulin and GRP78 verified the effective fractionation of
soluble and membrane-associated compartments (Figure 1B). The
results suggested that the translation initiation process was
suppressed by HIV-1 infection.
Next metabolic labeling experiments were performed on HIV-
1
NL4-3 infected CEMx174 cells. In parallel, aliquots of infected cells
were also treated with cycloheximide, which inhibits polypeptide
chain elongation during translation [38], or nocadozole, which
arrests cells in the G2/M phase of the cell cycle [39]. The cells were
labeled with
35S-methionine/cysteine for one hour, proteins were
precipitated, and the relative levels of de novo protein synthesis were
measured by scintillation. In comparison to mock-infected cells, the
35S-methionine/cysteine incorporation was significantly lower in
HIV-1-infected cells (p,0.0001) (Figure 2A, compare Mock to
HIV-1, reduction by 60%), indicating that HIV-1 infection reduces
de novo protein synthesis. The addition of nocadozole to uninfected
cells produced a similar reduction in de novo protein synthesis
(p,0.0001) (Figure 2B, compare Mock to Noc, reduction by 60%).
As expected, protein synthesis was eliminated by cycloheximide
(p,0.0001) (Figure 2B, compare Noc to CHX).
The addition of nocadozole to HIV-1-infected cells exacerbated
the reduction in cellular translation (p,0.0003) (Figure 2A,
compare HIV-1 to HIV-1+Noc, reduction by 60% and 75%,
respectively). The small cumulative decrease observed may be
attributed to the effect of nocadozole on the uninfected cells, or an
alternative inhibitory mechanism that augments HIV-1 induced
translation suppression. As expected, the addition of CHX to
HIV-1-infected cells eliminated cellular translation (p,0.0001)
(Figure 2A, compare HIV-1 to HIV-1+CHX), indicating that
HIV-1 infection reduces but does not completely shutdown host
protein synthesis. To correlate HIV-1-induced cell cycle arrest
with the protein synthesis activity of the cells, fluorescent activated
cell sorting (FACS) of PI-stained cells was performed. As expected,
HIV-1 infection increased the proportion of cells in the G2/M
phase relative to mock-infected cells (Figure 2A). The addition of
nocadozole to HIV-1-infected cells further increased the propor-
tion of cells in the G2/M phase (Figure 2A). By comparison, the
addition of nocadozole to uninfected cells increased the proportion
of cells in the G2/M phase of the cell cycle relative to untreated
cells in correlation with the reduction in protein synthesis
(Figure 2B).
Metabolic labeling followed by SDS-PAGE and autoradiogra-
phy of nocadozole-treated or HIV-1-infected cells showed
equivalent reductions in cellular translation in comparison to
mock-treated or mock-infected cells, respectively (Figure 2C top
panel). Parallel immunoprecipitation (IP) of HIV-1 Gag evaluated
the levels of de novo Gag synthesis after nocadozole or
cycloheximide treatment (Figure 2C bottom panel). The results
demonstrate that de novo Gag synthesis was sustained upon
nocadozole treatment and eliminated in the presence of
cycloheximide.
Figure 1. HIV-1 infection correlates with a subtle decrease in soluble and membrane-associated polyribosomes. (A) Representative
ribosomal RNA profile of mock or HIV-1-infected CEMx174 cells after sucrose gradient centrifugation and detection of the rRNA by absorbance at
254 nm. Labels designate the non-translating ribonucleoprotein complexes (RNPs) and adjacent peaks are 40S, 60S and 80S ribosome, respectively.
The translating RNP contains the polyribosomes. (B) Immunoblot with endoplasmic reticulum marker, GRP78 and cytosolic marker, a-Tubulin showed
effective fractionation of the membrane-associated and soluble cytosolic compartments of the infected CEMx174 cells.
doi:10.1371/journal.ppat.1002612.g001
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PLoS Pathogens | www.plospathogens.org 4 March 2012 | Volume 8 | Issue 3 | e1002612Figure 2. HIV-1 suppresses lymphocyte translation but HIV-1 gag translation is sustained. (A) Following HIV-1 infection and treatment
with nocodazole (Noc) or cyclohexamide (CHX), CEMx174 cells were incubated with [
35S]-cysteine/methionine for one hour and proteins were
precipitated with TCA. [
35S]-cysteine/methionine incorporation was measured by scintillation in three independent experiments and is presented
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nocadozole treatment on total protein synthesis, we investigated
whether HIV-1-induced cell cycle arrest is necessary for the
observed suppression of host translation. HIV-1-induced cell cycle
arrest has been attributed to the HIV-1 accessory proteins Vpr
and Vif and ablation of the vpr and vif open reading frames is
necessary to eliminate G2/M arrest [40,41,42]. CEMx174 cells
were infected with HIV-1 or derivative viruses deficient in vpr
(VprX) or vpr and vif (DVifVprX). FACS results demonstrated that
the HIV-1 infected cells were arrested in the G2/M phase,
whereas a partial G2/M arrest was observed for VprX-infected
cells, recapitulating published work that the deletion of vpr alone is
not sufficient to eliminate G2/M arrest (Figure 3A). Consistent
with published results, G2/M arrest was not observed in
DVifVprX-infected cells. The metabolic labeling results deter-
mined that the cellular protein synthesis was suppressed in cells
infected with HIV-1 (p,0.0001), but not DVifVprX (p=0.8062)
(Figure 3A, compare white bars). A partial suppression in protein
synthesis was observed for cells infected with VprX (p,0.0001). As
expected, nocadozoletreatment significantly suppressed translation
in all viral infections relative to the mock-infected cells (Figure 3A,
compare black bars). Metabolic labeling and IP results determined
that the Gag protein synthesis was sustained independent of the
virus used and was not reduced by nocadozole treatment
(Figure 3B). Consistent with the reduction in polyribosomes
observed in Figure 1A, de novo Actin synthesis was reduced during
HIV-1-infection and correlated with the cell cycle arrest
phenotype (Figure 3B).
Additional pulse-chase and Gag IP experiments investigated
whether Gag protein stability differed amongst the virus
derivatives. The results determined that the Gag protein half-life
was similar in each of the viral infections (Figure S1). Conse-
quently, HIV-1 induces a generalized suppression of host protein
synthesis due to virus- induced cell cycle arrest, but Gag protein
stability is unaffected.
To evaluate changes in Gag translation efficiency during G2/M
arrest, we analyzed gag mRNA translation during the course of
HIV-1 infection. Four independent replicate infections with HIV-
1o rDVifVprX were performed and representative results are
presented. HIV-1 or DVifVprX infections generated readily
detectable Gag protein by 12 h, and Gag protein synthesis
increased as the infections progressed (Figure 4). Aliquots of cells
were harvested for RNA isolation and RT-qPCR was performed
with gag and actin primers. During HIV-1 infection, the levels of
gag RNA peaked at 24 hour (Figure 4). Likewise actin protein and
mRNA levels peaked at 24 hour and declined in parallel with gag
mRNA levels. We attribute this trend to the declining cell viability
over the course of the HIV-1 infection. In the DVifVprX infection,
the gag mRNA levels continued to increase over the course of the
infection (Figure 4). The relative level of Gag protein synthesized
to gag mRNA was similar between HIV-1 and DVifVprX. The
results indicated that the expression of Vpr and Vif does not
significantly attenuate nor bolster the efficiency of Gag protein
synthesis. In sum, the HIV-1 protein synthesis is sustained during
virus-induced suppression of host translation.
Vpr-dependent cell cycle arrest is necessary and
sufficient to suppress cellular translation
Exogenous expression of Vpr is sufficient to induce cell cycle
arrest and this effect is attributed to polyubiquitination and
degradation of a yet-to-be-identified substrate protein [24,43,44].
To determine whether or not Vpr is sufficient for suppression of
cellular translation, HEK293 cells were transfected with an
epitope-tagged Vpr expression plasmid. Ectopic expression of
HA-Vpr was sufficient to suppress cellular protein synthesis
(Figure 5A, factor of 3, p,0.002,). Flow cytometry determined
that the cells were arrested at the G2/M phase (Figure 5A). HA
immunoblot verified the expression of HA-Vpr (Figure 5B).
Vpr-dependent cell cycle arrest is attributable to its interaction
with the Cul4A
DDB1/DCAF1 E3 ligase and a yet-to-be-identified
substrate for proteosome-mediated degradation [43,45,46,47,48,
49,50]. Genetic analyses have shown that the Q65R mutation
eliminates interaction with the DCAF1 subunit of the cullin 4a/
DDB1 E3 ubiquitin ligase while the R80A mutation sustains
DCAF1 interaction, but exhibits a loss of activity due to a defective
interaction with a yet-to-be defined host protein. Cells transfected
with the Vpr mutants R80A, Q65R or R80AQ65R [43] lacked
the G2/M arrest and did not suppress protein synthesis
(Figure 5A). Likewise, ectopic expression of Vif was not sufficient
for G2/M arrest and did not reduce protein synthesis (Figure 5A).
Immunoblotting verified equivalent expression of each protein
(Figure 5B). Taken together, the results indicated that the ectopic
expression of Vpr is sufficient to suppress cellular translation by
inducing cell cycle arrest.
HIV-1 infection reduces active eIF4E and increases the
inhibitory form of 4E-BP1
To address the underlying mechanism of HIV-1 translation
suppression, we assessed the phosphorylation status of host
translation factors by immunoblot [1,3,13,16,51,52,53,54,55]. As
shown in Figure 6A, treatment of HEK293 cells with double-
stranded RNA (polyIC) upregulated total eIF2a and Ser51-
phosphorylated eIF2a (P-eIF2a) (compare mock to polyIC).
Transfection of HEK293 cells with HIV-1 or DVifVprX provirus
did not perturb the levels of eIF2a or induce phosphorylation of
eIF2a (Figure 6A). However, expression of HIV-1 but not
DVifVprX reduced the abundance of Ser209-phosphorylated
eIF4E (P-eIF4E), independent of the changes in the total eIF4E
levels (Figure 6A, compare 24 hour and 48 hour). Evaluation over
12 hour intervals determined that the abundance of P-eIF4E and
Ser65-phosphorylated 4E-BP1 (P-4E-BP1) were reduced by HIV-
1 infection (see 36 hour), but not DVifVprX infection (Figure 6B,
compare HIV-1 to DVV). Furthermore, HIV-1 and DVifVprX
infections did not perturb the total protein levels of eIF4E and 4E-
BP1. Uniform sample loading was confirmed by a-Tubulin
immunoblot. The results demonstrated that the post-translation-
ally modified forms of eIF4E and 4E-BP1 were reduced in the
presence of HIV-1. PARP cleavage and reduction in the full-
length caspase-3 were observed by 48 hour, similar to the
etoposide treatment (Figure 6B, lower panels, compare etoposide
to HIV-1 and DVV) [56]. The onset of PARP cleavage and
with standard deviation. Asterisk indicates the significant reduction, p,0.05. Propidium iodide staining intensity and ModFit analysis demonstrates
the number and percentage of cells in the G1 or G2/M phase of the cell cycle. Percentages are summarized below the plots. (B) CEMx174 cells
received mock, nocadozole or CHX treatment. TCA precipitable counts and the cell cycle profiles were measured as described in (A). (C) Equivalent
whole-cell extracts were resolved by SDS-PAGE and labeled proteins were detected by the phosphorimager analysis. Percentage cellular translation
relative to the mock treatment or infection is summarized below the gel. Equivalent whole-cell extracts were subjected to immunoprecipitation after
metabolic labeling and proteins were resolved by SDS-PAGE and phosphorimager analysis is presented. Positions of Gag p55, p37 and p24 are
indicated.
doi:10.1371/journal.ppat.1002612.g002
HIV-1 Retains Nuclear RNP to Foster Translation
PLoS Pathogens | www.plospathogens.org 6 March 2012 | Volume 8 | Issue 3 | e1002612Figure 3. HIV-1 accessory proteins Vpr and Vif are necessary for HIV-1-induced suppression of cellular translation. (A) CEMx174 cells
infected with HIV-1, VprX, DVifVprX (DVV) or mock-infected were incubated with or without nocodazole (Noc) and then metabolically labeled with
[
35S]-cysteine/methionine for one hour and proteins were precipitated with TCA. [
35S]-cysteine/methionine incorporation was measured by
scintillation in three independent experiments and is presented with standard deviation. Asterisk indicates the significant reduction (p,0.05)a s
summarized in text for all of the infections except DVifVprX (p=0.8062). Nocadozole treatment significantly reduced the de novo protein synthesis in
all of the infections. Propidium iodide staining intensity and ModFit analysis demonstrates the number and percentage of cells in the G1 or G2/M
phase of the cell cycle. Percentages are summarized below the plots. (B) Comparison of de novo HIV-1 Gag and cellular Actin protein production with
or without nocadozole treatment. CEMx174 cells were metabolically labeled with [
35S]-cysteine/methionine for one hour, followed by
immunoprecipitation with antisera to Gag and Actin. The immunoprecipitated proteins were resolved by SDS-PAGE and phosphorimager analysis
is presented. Positions of Actin and Gag p55, p37 and p24 are indicated.
doi:10.1371/journal.ppat.1002612.g003
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phosphorylated forms or total amounts of eIF4E or 4E-BP1. In
summary, the results suggest that the molecular basis of HIV-1
translation suppression is the downregulation of eIF4E function.
To determine whether or not Vpr-induced cell cycle arrest is
sufficient for the impairment of eIF4E activity, HEK293 cells were
transfected with HA-Vpr or the Vpr mutants deficient in cell cycle
arrest. The samples were evaluated relative to serum deprivation,
which downregulates translation by reducing the phosphorylated
form of selected translation factors [57,58,59]. Consistent with
previous reports, serum deprivation reduced and increased the
levels of P-4E-BP1 and P-eIF2a, respectively, without affecting the
total protein levels (Figure 7A, compare + serum to 2 serum). By
comparison, nocadozole treatment of CEMx174 cells reduced P-
4E-BP1 and P-eIF4E, but not P-eIF2a (Figure 7A, compare + Noc
to 2 Noc). Both serum deprivation and nocadozole treatment
increased the levels of Thr197/202-phosphorylated Mnk1 (P-
Mnk1) (Figure 7A, compare 2 serum to + Noc).
Ectopic expression of Vpr was sufficient to reduce the levels of
P-4E-BP1 and P-eIF4E (Figure 7B, compare Vpr to Empty
plasmid). The reduction was not observed when Vif or the Vpr
mutants deficient in G2/M arrest were expressed (Figure 7B,
compare Vpr to R80A, Q65R, R80AQ65R and Vif). Moreover,
Mnk1 levels were unaffected and P-Mnk1 was not detected
(Figure 7B), indicating that the underlying mechanism for Vpr-
mediated translation suppression is distinct from serum depriva-
tion (nutritional stress) or nocadozole treatment. Future investiga-
tion of the possible roles of Mnk2 and other components of the
mTOR pathway is warranted. Equivalent expression of HA-
tagged Vpr proteins and Vif was verified by HA and Vif antisera,
respectively. The exogenous expression of Vpr did not affect
PARP levels indicating that the downregulation of the active
eIF4E was not attributable to apoptosis or poor cell viability
(Figure 7B) [60,61]. These results indicate that the downregulation
of translation by Vpr is associated with reduced accumulation of P-
eIF4E and P-4E- BP1.
HIV-1 gag RNA remains bound to nuclear cap binding
protein in the cytoplasm
Our observation of sustained Gag protein synthesis despite
reduced eIF4E activity suggested that the gag mRNP circumvents
downregulation of eIF4E-dependent translation and may interact
with the translational apparatus in a distinct fashion. One
hypothesis is that the gag RNP uses the nuclear CBC to initiate
translation. The CBC components, CBP80 and CBP20, are
normally subject to competitive binding by importin-beta, which
drives their nuclear reimport and efficient exchange for eIF4E
[19,62]. To assess whether HIV-1 infection alters CBC nucleo-
cytoplasmic distribution, sub-cellular fractionation and immuno-
blots with antisera to CBP80, a-tubulin and histone H1 were
performed. The results demonstrated that the abundance of
CBP80 was similar between mock and HIV-1 infected cells
(Figure 8A, compare Mock to HIV-1). As expected, CBP80 and
histone H1 were prominent in the nucleus and a-Tubulin was
prominent in the cytoplasm. Furthermore, HIV-1 infection did not
affect cytoplasmic abundance of CBP80 (Figure 8A, compare
Mock to HIV-1). To investigate the interaction of CBC and eIF4E
with HIV-1 gag RNA, mRNPs were immunoprecipitated from
cytoplasmic fractions. Immunoblots confirmed CBP80 and eIF4E
were specifically immunoprecipitated with their respective antisera
Figure 4. HIV-1 gag mRNA translation is resistant to suppression of global cellular translation. CEMx174 cells were infected with HIV-1 or
DVifVprX (DVV) and evaluated at 12 hour intervals post-infection. At indicated intervals, replicate cultures were metabolically labeled with [
35S]-
cysteine/methionine for one hour and proteins immunoprecipitated with antisera to Gag and Actin. The immunoprecipitated proteins were resolved
by SDS-PAGE and phosphorimager analysis is presented. Positions of Actin and Gag p55, p37 and p24 are indicated. In parallel, RNA was harvested
and RT-qPCR with gag or actin primers was performed to measure RNA copy numbers. The ratio of the RNA copy numbers is presented.
doi:10.1371/journal.ppat.1002612.g004
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and eIF4E to IgG). RNA was harvested from cells or the co-
precipitates and subjected to reverse transcription and PCR with
primers complementary to gag, nef,o rGAPDH. As expected, gag
and nef RNAs were observed solely in the RNA preparations from
HIV-1 infected cells (Figure 8C, lanes 1, 3, 7, 11), whereas
Figure 5. Vpr is sufficient for the cell cycle arrest and suppression of cellular translation. (A) HEK 293 cells were transfected with IRESgfp
(Empty plasmid), bicistronic VprIRESgfp expression plasmid that encodes Vpr or indicated substitution mutants, or IRESgfp plus Vif expression
plasmid. GFP-positive cells were sorted and metabolically labeled with [
35S]-cysteine/methionine for one hour, followed by TCA precipitation and
scintillation. The histogram presents average TCA precipitable counts of the incorporated [
35S] and the standard deviation from three independent
experiments. Asterisk indicates a significant reduction in de novo protein synthesis (p=0.0019) in response to Vpr. Propidium iodide staining intensity
and ModFit analysis determined the number and percentage of cells in the G1 or G2/M phase of the cell cycle. Percentages are summarized below
the plots. (B) Equivalent whole-cell extracts were immunoblotted with HA antibody to detect epitope tagged Vpr, and antiserum against Vif, PARP
and b-Actin, respectively.
doi:10.1371/journal.ppat.1002612.g005
Figure 6. Suppression of cellular translation is attributable to HIV-1-dependent dephosphorylation of eIF4E and 4E-BP1. (A) HEK 293
cells were transfected with HIV-1
NL4-3 or DVifVprX (DVV) for 24 or 48 hour, as indicated. Equivalent whole-cell extracts were immunoblotted with
antiserum against phospho-eIF2a Ser51, total eIF2a, phospho-eIF4E Ser209 or total eIF4E, respectively. (B) CEMx174 cells were infected with HIV-1 or
DVifVprX (DVV) and evaluated at 12 hour intervals. Equivalent whole-cell extracts were immunoblotted with the indicated antiserum.
doi:10.1371/journal.ppat.1002612.g006
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cells (Figure 8C, lanes 1–2). Consistent with expectations, GAPDH
RNA exhibited prominent association with eIF4E (Figure 8C,
compare lanes 7 and 8 to 11 and 12). In contrast, the HIV-1
transcripts exhibited a differential pattern of eIF4E association.
Unspliced gag RNA was abundant in the CBP80 RNP, while
multiply spliced nef RNA was abundant in the eIF4E RNP
(Figure 8C, compare lanes 8 and 12). The isotype control IgG IP
lacked detectable levels of nef and GAPDH RNA (Figure 8C,
lanes 3–6) or showed background levels of gag RNA (Figure 8C,
lane 4). No amplification products were detected in the absence of
RT (RT2) (Figure 8C, lanes 5, 6, 9, 10, 13, 14) or cDNA
(Figure 8C, lane 15, water control). The results demonstrate that
the cytoplasmic HIV-1 gag mRNA is predominantly associated
with CBC, whereas nef and GAPDH mRNAs are predominantly
associated with eIF4E. In sum, the spliced HIV-1 mRNA
undergoes CBC exchange for eIF4E, while unspliced HIV-1
mRNA remains associated with the CBC in the cytoplasm.
CBP80 is a component of the translating HIV-1 gag RNP
A possible mechanism by which unspliced HIV-1 mRNA
circumvents downregulation of eIF4E-dependent translation is the
use of the CBC-associated mRNAs to engage the translation
apparatus. To test this hypothesis, HEK293 cells were transfected
with HIV-1
HxBruR2/RI2 provirus and cytoplasmic extracts were
prepared and fractionated on 15–45% sucrose gradients [30].
Replicate sucrose gradients were performed in the presence of
EDTA, which dissociated the polysomes and produced an upward
shift of ribosomal RNAs in the gradients (Figure 9A, fractions 13–
21, compare 2EDTA to +EDTA). Alternating gradient fractions
Figure 7. Vpr expression is sufficient to reduce the levels of phosphorylated eIF4E and 4E-BP1. (A) Serum deprivation or
pharmacological cell cycle arrest is sufficient to reduce accumulation of phosphorylated eIF4E and 4E-BP1. HEK 293 cells were incubated in complete
medium (serum +) or in low serum medium (2serum) for 24 hour. Equivalent whole-cell extracts were harvested and immunoblotted with phospho-
eIF4E Ser209, total eIF4E, phospho-4E-BP1 Ser65, total 4E-BP1, phospho-Mnk1 Thr197/202, total Mnk1, phospho-eIF2a Ser51 and total eIF2a,
antibodies respectively (left panel). CEMx174 cells were incubated in complete medium that lacked or contained nocodazole (Noc) for 24 hour, and
equivalent whole-cell extracts were immunoblotted with the indicated antiserum. (B) HEK 293 cells were transfected with expression plasmids
encoding Vpr, indicated Vpr substitution mutant, or Vif, and whole-cell extracts were immunoblotted with the indicated antiserum.
doi:10.1371/journal.ppat.1002612.g007
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number). Immunoblots demonstrated that eIF4E is in both the
nontranslating mRNPs (Figure 9B, fraction 1, 2EDTA) and
polysome fractions (Figure 9B, fractions 13–21, 2EDTA). EDTA
treatment induced an upward shift of eIF4E and eIF4E was most
abundant in the 80S ribosomal fraction (Figure 9B, fraction 9,
+EDTA). In comparison, CBP80 was not seen in nontranslating
mRNPs (Figure 9B, fraction 1, 2EDTA), but was detected in the
80S ribosomal fractions (Figure 9B, fractions 9–11, 2EDTA) and
the fractions containing polysomes (Figure 9B, fractions 13–17,
2EDTA). The EDTA treatment produced an upward shift in the
CBP80 that was less prominent than the shift in eIF4E (Figure 9B,
compare 2EDTA to +EDTA). The shifted CBP80 became
detectable in the nontranslating RNPs (Figure 9B, fractions 1–5,
+EDTA) and was most abundant in the 80S ribosomal fractions
(Figure 9B, fractions 9–11, +EDTA). Taken together, these results
demonstrate that CBP80 bound RNPs are predominately engaged
in translation.
RPAs were used to examine the distribution of HIV-1 and actin
mRNAs across the same sucrose gradients. The HIV-1 RNA
probe used is complementary to the 59 splice site of HIV-1 and
hence measured the abundance of unspliced gag transcript (US)
and spliced viral mRNAs (S) (inclusive of the singly-spliced 4 kb
and multiply-spliced 2 kb HIV-1 mRNAs) [36,37]. The actin RPA
probe served to control for the minor variations in the sample
processing. As shown in Figure 9C, all probed mRNAs were
predominately found in the polysome fraction of the gradient.
Treatment with EDTA produced an upward shift in the HIV-1
RNAs, demonstrating that the sedimentation of the RNAs was
dependent on the interaction with ribosomes (Figure 9C, fractions
16–22, 2EDTA). In summary, the results indicate that the CBC-
bound HIV-1 gag mRNA undergoes active translation.
CBP80 is a component of HIV-1 virions
The observation that the HIV-1 unspliced mRNPs retains
association with the CBC during translation raised the possibility
Figure 8. Cytoplasmic HIV-1 gag mRNA retains interaction with CBP80 in the cytoplasm. (A) CEMx174 cells infected with HIV-1 or mock-
infected were used to harvest total cellular protein (Total) and the nuclear (Nuc) and cytoplasmic (Cyto) compartments. Equivalent aliquots were
immunoblotted with the indicated antiserum. (B) Cytoplasmic lysates from (A) were subjected to immunoprecipitation with CBP80 (top) or eIF4E
(bottom) antibodies. Immunoblotting of equivalent aliquots of input and the immunoprecipitated material determined that the IP efficiency was
similar between the lysates. Specificity of the IP was verified by using IgG isotype control. (C) Immunoprecipitates from (B) were used to harvest RNA,
which were subjected to reverse transcription reactions with or without reverse transcriptase (RT + or 2), followed by gene-specific PCR. Products
were separated by agarose gel electrophoresis. The gag, nef or GAPDH amplification products from control Total RNA preparation (lanes 1, 2) and
RNA-immunoprecipitates (lanes 3–15) are indicated. Lane 15 (No DNA) indicates PCR reaction contained water in place of cDNA.
doi:10.1371/journal.ppat.1002612.g008
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investigate this possibility, virions were harvested and subjected
to Gag ELISA and equivalent virion RNPs were subjected to
immunoblot. Immunoblots of cell-associated proteins from
uninfected or HIV-1-infected CEMx174 cells showed no change
in abundance or size of CBP80 and eIF4E (Figure 10, compare
Mock to HIV-1). Parallel testing of purified virions detected both
CBP80 and eIF4E (Figure 10, right panel showing HIV-1 virions).
Parallel testing of cell-free medium harvested from the uninfected
cells eliminated the possibility of contamination with cellular
material (Figure 10, compare 0 ng to 2000 ng Gag). Notably, an
additional polypeptide was detected by eIF4E antiserum, which is
smaller and ,2-fold more abundant than eIF4E. The identity of
this polypeptide will be determined in the future. Equivalent
loading of virion preparation was verified using antiserum to
known virion components, host RNA helicase A (DHX9) [33] and
capsid protein, Gag p24. These results demonstrate that the CBC
remains associated with the HIV-1 unspliced RNA undergoing
encapsidation.
Discussion
Our study of HIV-1-host interaction has generated new and
fundamental insight into the translational control of HIV-1
mRNAs and the HIV-1 infected cell. Using multiple approaches,
we demonstrated that the host cell translation is suppressed during
acute HIV-1 infection, an effect associated with reduced levels of
phosphorylated eIF4E and 4E-BP1. The changes in protein
modification and translation are in response to the cell cycle arrest
induced by the viral accessory protein Vpr. Exogenous expression
of Vpr is sufficient for global translation suppression and mutations
that ablate Vpr-induced cell cycle arrest eliminate this effect.
Despite the reduction in total protein synthesis, HIV-1 sustains
translation of its structural and enzymatic proteins. We hypoth-
esize that this effect is attributable to the unique composition of the
viral RNP, in particular the retention of its interaction with the
nuclear cap binding complex (CBC) throughout its lifetime in the
cytoplasm. These findings outline a novel viral strategy to
circumvent downregulation of eIF4E-dependent translation, a
Figure 9. CBP80 and eIF4E co-sediment with the polyribosomes. (A) HEK293 cells were transfected with HIV-1
HxBruR2/RI2 for 48 hour,
cytoplasmic extracts were harvested, incubated in buffer with or without EDTA, and separated on 15–47.5% linear sucrose density gradients.
Representative A254 ribosomal RNA profiles are indicated. (B) Lysates from every other fraction were immunoblotted with CBP80 and eIF4E
antibodies. (C) RNA was isolated and subjected to RNase protection assays with
32P-labeled antisense RNA probe complementary to the HIV-1 59 UTR
and gag or actin, respectively. Detection products are the unspliced HIV-1 RNA (US), spliced HIV-1 transcripts (S) and cellular actin RNA.
doi:10.1371/journal.ppat.1002612.g009
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mRNAs during conditions of cellular stress. The retention of CBC
on the mRNA allows for continued viral mRNA translation when
global translation is reduced by limited eIF4E function, such as
during cellular stress response, induction of apoptosis, and
progression from the G2/M phase of the cell cycle [63]. We
hypothesize that CBC-bound HIV-1 mRNAs and selected host
mRNAs represent a novel class of RNA regulon [64] whose
protein products need to be synthesized during conditions of
limited eIF4E activity.
Previous studies have determined that CBC is required for the
nuclear export of U snRNA to the cytoplasm [65,66] and U
snRNP assembly [67]. The U snRNA is tethered to the CRM1
nuclear export receptor by the phosphorylated adapter for RNA
export (PHAX) protein [68]. In the case of incompletely spliced
HIV-1 RNAs, the tethering function is provided by the virus-
encoded adapter protein Rev. Rev interacts with the cis-acting
Rev responsive element (RRE) in the env open reading frame and
mediates the export of the unspliced viral RNAs to the cytoplasm,
in a CRM1-RanGTP-dependent manner [21,69]. In contrast,
completely spliced viral mRNAs utilize NXF1/NXT1, the same
adaptor proteins used by the spliced cellular mRNAs. Once in the
cytoplasm, the RNP undergoes rearrangement, part of which
involves the exchange of the CBC for cytoplasmic eIF4E. The
CBC is then reimported into the nucleus by importin-a [67].
Biophysically, CBC and eIF4E employ two aromatic side chains
to interact with the 7-methylguanine of the bound mRNA in an
induced-fit structure [70]. However, the CBC has significantly
greater affinity for the 7-methylguanosine cap structure than
eIF4E [71]. Interaction with the translation initiation cofactor
eIF4G is necessary to provide eIF4E with a competitive advantage
for binding 7-methylguanosine cap structure [72]. However,
recent work by Yedavalli and Jeang determined that cytoplasmic
unspliced HIV-1 RNA has a tri-methlyguanosine cap, making
these RNAs structurally distinct from cellular mRNAs, which have
a mono-methylguanosine cap [73]. The difference in RNA cap
structure is a function of the export pathway used since the same
RNA sequence transported via NXF1/NXT1 lacked the tri-
methlyguanosine modification. We hypothesize that the distinct
modifications of the 59-cap generates a unique molecular signature
that dictates the fate of this mRNA template during G2/M phase,
cellular stress that limits eIF4E activity, and/or stimulation of the
innate immune response [74]. Biophysical measurements have
determined that the CBC has a ,100 fold higher affinity for tri-
methylguanosine relative to mono-methylguanosine [71]. Such
differences in affinity may provide a mechanism for preferential
retention of the CBC by HIV-1 gag mRNA allowing it to
circumvent reduced eIF4E-dependent translation, sustain viral
protein synthesis and remain bound during virion assembly.
Selective translation of HIV-1 structural protein mRNAs may also
be facilitated by a distinct set of interactions that mediate
translation initiation of the CBC-bound mRNAs. A recent study
determined that CBC-bound mRNAs had a selective advantage in
engaging the translational apparatus [75] perhaps as a result of
using different factors (CTIF versus eIF4G) to support translation
[76]. The possibility that CBC retention is a result of the presence
of an IRES within HIV-1 unspliced RNA was also considered. To
address this issue, we evaluated HIV-1 Rev-dependent env RNA
that lacks the previously mapped IRES [77,78,79]. As shown in
the supplementary material (Figures S2 and S3), the env transcript
that lacks the IRES maintained the preferential retention of CBC
and the spliced product was associated with eIF4E.
The differences by which HIV-1 mRNAs engage the transla-
tional machinery may be important to allow HIV-1 to subvert
NMD [80]. Both unspliced and singly spliced HIV-1 RNAs have
multiple termination codons throughout the sequence that would
normally signal degradation by NMD. Other retroviruses, such as
the Rous sarcoma virus, use an RNA stability element to
antagonize recognition of premature termination codons [81,82].
In a similar fashion, the distinct composition of the HIV-1 RNPs
may serve to antagonize the induction of the NMD, by preventing
recognition of termination codons present in the incompletely
spliced and unspliced HIV-1 mRNAs.
Taken together, the data presented in this report indicate that
the unspliced and singly spliced HIV-1 transcripts have a distinct
pattern of regulation from the bulk of host mRNA in the
cytoplasm, conferred, in part, by differences in the composition of
the RNPs. Such differences permit HIV-1 to maximize viral
protein synthesis and virion production under conditions that
reduce cell survival. Our discovery also opens new avenues to
investigate the mechanistic control of CBC/eIF4E cap exchange
that is fundamental to translational regulation in all metazoan
cells.
Supporting Information
Figure S1 Gag proteins with similar stability are
expressed from HIV-1 and the derivatives viruses.
CEMx174 cells were infected with HIV-1, DVifVprX (DVV) or
VprX for 48 hour. The infected cells were metabolically labeled
with [
35S]-cysteine/methionine for one hour, washed and
incubated for indicated intervals after the addition of complete
medium. Equivalent volumes of cells were subjected to immuno-
precipitation and proteins were resolved by SDS-PAGE and
phosphorimager analysis is presented. Positions of Gag p55, p37
and p24 are indicated.
(TIF)
Figure S2 CBP80 and eIF4E co-sediment with poly-
somes in cells transfected with subgenomic HIV-1 env
plasmid. (A) HEK 293 cells were transfected with pgTat and
Figure 10. CBP80 is incorporated into HIV-1 virions. Cellular
protein and cell-free supernatant medium from CEMx174 cells or
CEMx174/HIV-1 were harvested and subjected to immunoblot. Virions
in the medium were collected by ultracentrifugation, subjected to Gag
ELISA and the indicated aliquots (0 to 2000 ng) were evaluated with the
indicated antisera.
doi:10.1371/journal.ppat.1002612.g010
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incubated with or without EDTA, and applied to 15–47.5% linear
sucrose density gradients. Representative A254 ribosomal RNA
profiles are indicated. (B) Lysates from every other fraction were
immunoblotted with CBP80 and eIF4E antibodies. (C) RNase
protection assays of RNA isolated from every other fraction.
Designations indicate the unspliced (US) reporter transcript;
spliced (S) env RNA; and cellular actin RNA.
(TIF)
Figure S3 Unspliced pgTat mRNA coprecipitates with
CBP80 and the spliced env transcript coprecipitates with
eIF4E. (A) HEK 293 cells were transfected with pgTat and
pCMVRev for 48 hour. Equivalent cytoplasmic lysates were
immunoprecipitated with the isotype control (IgG), eIF4E or
CBP80 antibodies. (B) Graphical representation of pgTat
indicating the position of the RPA probe used (top). RNase
protection assays of RNA isolated from the immunoprecipitations.
Designations are unspliced (US) pgTat transcript and spliced (S)
env transcript.
(TIF)
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